Our present data indicate that the higher capacity of nonectopic lipid storage along with lower hepatic pathogen recognition and subsequent lower upregulation of lipogenic and inflammatory pathways compared to APOE3 may be involved in the NASH-preventing activity of APOE4 in targeted replacement mice. This evidence concerns the gene APOE and metabolic dysfunction-associated steatohepatitis.